REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $161,707 | +9.1% | 5,842 | +5.5% | 0.01% | +14.3% |
Q2 2023 | $148,195 | +47.1% | 5,540 | +19.1% | 0.01% | +40.0% |
Q1 2023 | $100,719 | -9.3% | 4,650 | -0.2% | 0.01% | 0.0% |
Q4 2022 | $111,025 | +25.6% | 4,661 | +4.0% | 0.01% | +25.0% |
Q3 2022 | $88,365 | +16.1% | 4,481 | +14.8% | 0.00% | +33.3% |
Q2 2022 | $76,108 | -23.6% | 3,905 | 0.0% | 0.00% | -25.0% |
Q1 2022 | $99,617 | -76.1% | 3,905 | -76.4% | 0.00% | -33.3% |
Q4 2021 | $416,513 | -8.5% | 16,548 | 0.0% | 0.01% | -14.3% |
Q3 2021 | $455,235 | -13.3% | 16,548 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $525,234 | +3.1% | 16,548 | +49.0% | 0.01% | -12.5% |
Q1 2021 | $509,681 | +12.6% | 11,109 | -2.9% | 0.01% | +14.3% |
Q4 2020 | $452,751 | +13.8% | 11,436 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $397,973 | +154.2% | 11,436 | +130.6% | 0.01% | +133.3% |
Q2 2020 | $156,556 | +44.1% | 4,959 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $108,652 | – | 4,959 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |